HSD88 Current Epcoritamab Plus Rituximab and Lenalidomide (R2) Perceptions for Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
Abstract
Authors
E Levine D Gentile R Swain R.N. Bone L. Jennings-Zhang Y. Jeune-Smith B Feinberg